CMC efforts for MAB114 for the development and treatment of ebola.

Ended Definitive Contract Awarded Last action

Contract number
75A50120C00009
Awardee
Awarding agency
Obligated
$19,311,430

Award facts

Opportunity
Contract value 12% obligated
  • $19,311,429.50 Current, with exercised options
  • $159,105,330.50 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Coconut Grove, FL 33133, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 -$455,905
Other Administrative Action P00015 · This modification DE-obligates canceling year funds from requisition OS251050 in the amount of $428,800.23 from base/CLIN0001, update articles F.2.… -$428,800
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $1,495,681
Other Administrative Action P00007 $3,437,319
Funding Only Action P00006 $1,393,650
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $2,961,886
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $10,907,600
Show all 17

About this award

Written by GovTribe AI ·

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Ridgeback Biotherapeutics LP for development and treatment of Ebola (mAb114) on March 19, 2020, under a sole-source justification.

The contract ceiling is $159,105,330.50 on a cost-plus-fixed-fee basis. The originating Special Notice, posted February 12, 2020, identified Ridgeback Biotherapeutics as the only responsible source capable of satisfying the requirement due to completed technology transfer and manufacturing of mAb114. The solicitation estimated base contract value at $10.9 million with optional scope valued at up to $150.7 million to support manufacturing and development activities necessary to submit a Biologics License Application for mAb114, with advancement to approval targeted for July 2020. Place of performance is Coconut Grove, Florida. The contract has been modified; the current summary reflects a decrease of $455,905.15 due to de-obligation of year funds from two requisitions as of the most recent modification.

Quick answers

Who was awarded contract 75A50120C00009?

75A50120C00009 was awarded to Ridgeback Biotherapeutics LP by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 19, 2020.

How much is contract 75A50120C00009 worth?

The government has obligated $19,311,430 on 75A50120C00009. Its potential value, with all options, is $159,105,331.

Was contract 75A50120C00009 competed?

The extent of competition for 75A50120C00009 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login